期刊文献+

组蛋白去乙酰化酶抑制剂SAHA对小鼠淋巴细胞增殖和凋亡的影响 被引量:2

Effects of histone deacetylase inhibitor SAHA on proliferation and apoptosis of mouse lymphocytes
原文传递
导出
摘要 研究辛二酰苯胺异羟肟酸(SAHA)对小鼠淋巴细胞活化、增殖和凋亡的影响,并对其免疫调控机制进行初步探讨。以MTS检测淋巴细胞的增殖情况;以双色荧光抗体染色技术结合流式细胞术检测SAHA对T淋巴细胞早期活化抗原CD69表达的影响;采用碘化丙锭(PI)染色检测SAHA对淋巴细胞周期的影响;以Annexin V-PE染色分析细胞凋亡;应用免疫印迹检测SAHA对Cleaved caspase-3表达的影响。结果显示,SAHA对Con A刺激的淋巴细胞增殖具有抑制作用,其IC50为0.30±0.06μmol/L;SAHA对淋巴细胞的早期活化抗原CD69的表达具有明显的抑制作用(P<0.05);PI染色、Annexin V-PE染色和免疫印迹结果均显示,SAHA对小鼠淋巴细胞的凋亡具有促进作用,且呈剂量依赖性。研究表明,SAHA可能通过抑制小鼠淋巴细胞的活化、增殖以及促进其凋亡而发挥免疫调控功能。 We aimed to investigate the effects of suberoylanilide hydroxamic acid(SAHA) on the activation,proliferation and apoptosis of murine lymphocytes activated with concanavalin A(ConA) to elucidate it's immunomodulatory mechanism.MTS assay was adopted to analyze the proliferation of mouse lymphocytes.The expression level of CD69 on the surface of CD3+ T lymphocytes was evaluated by double fluorescent staining together with flow cytometry.Propidium iodide(PI) staining was used to analyze the cell cycle distribution.Cell apoptosis was analyzed by Annexin V-PE staining.The level of cleaved caspase-3 was detected by Western blotting.Our results demonstrated that SAHA inhibited the proliferation of ConA-activated lymphocytes with an IC50 of 0.30±0.06 μmol/L.The expression of CD69 on CD3+ T lymphocytes was significantly inhibited by SAHA(P0.05).Furthermore,analysis of sub-G0/G1 peaks,Annexin-V binding populations and caspase-3 activation revealed that SAHA induced apoptotic cell death in activated lymphocytes.These findings suggest that induction of apoptosis and inhibition of activation and proliferation may contribute to the immunomodulatory activities of SAHA in murine lymphocytes.
出处 《现代免疫学》 CAS CSCD 北大核心 2012年第1期46-51,共6页 Current Immunology
基金 国家自然科学基金资助项目(81173604) 中央高校基本科研业务费专项资金项目(21609403)
关键词 组蛋白去乙酰化酶抑制剂 SAHA 淋巴细胞 增殖 细胞凋亡 免疫调控 histone deacetylase inhibitor suberoylanilide hydroxamic acid lymphocytes proliferation apoptosis immunomodulatory
  • 相关文献

参考文献14

  • 1Fournel M,Trachy-Bourget MC,Yan PT,et al.Sulfona-mide anilides,a novel class of histone deacetylase inhibitors,are antiproliferative against human tumors[J].Cancer Res,2002,62:4325-4330.
  • 2Johnstone RW.Histone-deacetylase inhibitors:novel drugsfor the treatment of cancer[J].Nat Rev Drug Discov,2002,1:287-299.
  • 3Reddy P,Maeda Y,Hotary K,et al.Histone deacetylase in-hibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemiaeffect[J].Proc Natl Acad Sci USA,2004,101:3921-3926.
  • 4Khan ANH,Tomasi TB.Histone deacetylase regulation ofimmune gene expression in tumor cells[J].Immunol Res,2008,40:164-178.
  • 5Itoh Y,Suzuki T,Miyata N.Isoform-selective histone deacetylaseinhibitors[J].Curr Pharm Des,2008,14:529-544.
  • 6Marks PA,Rifkind RA,Richon VM,et al.Histone deacety-lases and cancer:causes and therapies[J].Nat Rev Cancer,2001,1:194-202.
  • 7Blagosklonny MV,Robey R,Sackett DL,et al.Histonedeacetylase inhibitors all induce p21but differentially causetubulin acetylation,mitotic arrest,and cytotoxicity[J].MolCancer Ther,2002,1:937-941.
  • 8Kim HJ,Bae SC.Histone deacetylase inhibitors:molecularmechanisms of action and clinical trials as anti-cancer drugs[J].Am J Transl Res,2011,3:166-179.
  • 9李颖,徐林.CD4^+CD25^+Foxp3^+调节性T细胞研究的新进展[J].现代免疫学,2010,30(6):520-523. 被引量:17
  • 10周晓荣,周芸,周光炎,季玉红,汪晓莺.SAHA抑制经Ⅱ型胶原体内致敏的Th1细胞增殖与凋亡[J].现代免疫学,2009,29(6):470-474. 被引量:2

二级参考文献24

  • 1Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) . Breakdown of a single mechanism of sell--tolerance causes various autoimmune diseases [J]. J Immunol, 1995, 155 : 1151-1164.
  • 2Hanabuchi S, Ito T, Park WR, etal. Thymic stromal lymphopoietin activated plasmacytoid dendritic cells induce the generation of FOXP3^+ regulatory T cells in human thymus [J]. J Immunol, 2010, 184:2999-3007.
  • 3Martin-Gayo E, Sierra Filardi E, Corb AL, et al. Plasmacytoid dendritic cells resident in human thymus drive natural Tregs cell development [J]. Blood, 2010, 115:5366-5375.
  • 4Vang KB, Yang J, Pagdn AJ, et al. Cutting edge: CD28 and e Rel-dependent pathways initiate regulatory T cell development [J]. J Immunol, 2010, 184: 4074-4077.
  • 5Lio CW, Dodson LF, Deppong CM, et al. CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors [J]. J Immunol, 2010, 184:6007-6013.
  • 6Rouas R, Fayyad Kazan H, E1 Zein N, etal. Human natural Treg microRNA signature: role of microRNA-31 and microRNA 21 in FOXP3 expression [J]. Ear J Immunol, 2009, 39: 1608-1618.
  • 7Torgerson TR, Genin A, Chen C, et al. FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector eytokine expression[J]. J Immunol, 2009, 183: 907-915.
  • 8Zheng Y, Josefowicz S, Chaudhry A, et al. Role of conserved non coding DNA elements in the Foxp3 gene in regulatory T cell fate [J].Nature, 2010, 463: 808-812.
  • 9Prochazkova J, Fric J, Pokorna K, et al. Distinct regulatory roles of transforming growth factor-beta and interleukin 4 in the development and maintenance of natural and induced CD4^+CD25^+ Foxp3^+ regulatory T cells [J]. Immunology, 2009, 128: 670-678.
  • 10Turner MS, Kane LP, Morel PA. Dominant role of antigen dose in CD4^+ Foxp3^+ regulatory T cell induction and expan sion [J]. J Immunol, 2009, 183:4895-4903.

共引文献17

同被引文献35

  • 1杨凯,郑刚.葫芦素BE的药理作用研究进展[J].国际中医中药杂志,2006,28(1):27-29. 被引量:22
  • 2王颖,王生余,侯春梅,徐元基,杜芝燕,于晓妉.组蛋白去乙酰化酶抑制剂SAHA阻断MAPK信号通路并诱导HL-60细胞凋亡[J].中国实验血液学杂志,2007,15(2):267-271. 被引量:3
  • 3Kim DH, Kim M, Kwnn HJ. Histone Deacetylase in carcinogenesis and its inhibitors as anti-cancer agents [ J ]. J Biochem Mol Biol, 2003,36( 1 ) :110-119.
  • 4Mann BS,Johnson JR, Cohen MH, et al. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lym- phoma [ J ]. Oncologist, 2007,2 ( 10 ) : 1247-1252.
  • 5Yin D, Ong JM, Hu J, et al. Suberoylanilide hydroxamic acid, a his- tone deaeetylase inhibitor:effects on gene expression and growth of glioma cells in vitro and in vivo[ J]. Clin Cancer Res,2007,13 (3) :1045-1052.
  • 6Jin JS, Tsao TY, Sun PC, et al. SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of eye- lin D1 and survivin[ J]. Patho] Oneol Res ,2012,18 ( 3 ) :713-720.
  • 7Munster PN, Troso-Sandoval T, Rosen N, et al. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces dif- ferentiation of human breast cancer cells[ J]. Cancer Res,2001,61 ( 23 ) : 8492-8497.
  • 8Kwon A, Park HJ, Back K, et al. Suberoylanilide hydroxamic acid enhances odontoblast differentiation [ J ]. J Dent Res,2012,91 ( 5 ) : 506-512.
  • 9Gillenwater AM, Zhong M, Lotan R. Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mi- tochondrial and Fas( CD95 ) Signaling in head and neck squamous carcinoma cells[J]. Mol Cancer Ther,2007,6( 11 ) :2967-2975.
  • 10Ruefli AA, Bernhard D,Tainton KM,et al. Suberoylanilide hydrox- amic acid(SAHA) overcomes muhidrug resistance and induces cell death in P-glycoprotein-expressing cells[ J]. Int J Cancer,2002,99 ( 2 ) :292-298.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部